Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Avai Bio (AVAI) Depreciation Expense (2018 - 2024)

Avai Bio's Depreciation Expense history spans 3 years, with the latest figure at $14378.0 for Q4 2020.

  • On a quarterly basis, Depreciation Expense rose 75.56% to $14378.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $56949.0, a 154.73% increase, with the full-year FY2024 number at $1500.0, changed N/A from a year prior.
  • Depreciation Expense hit $14378.0 in Q4 2020 for Avai Bio, up from $14256.0 in the prior quarter.
  • Over the last five years, Depreciation Expense for AVAI hit a ceiling of $16748.0 in Q1 2020 and a floor of $2165.0 in Q4 2018.
  • Historically, Depreciation Expense has averaged $9052.3 across 3 years, with a median of $9837.0 in 2019.
  • The widest YoY moves for Depreciation Expense: up 673.58% in 2020, down 44.92% in 2020.
  • Tracing AVAI's Depreciation Expense over 3 years: stood at $2165.0 in 2018, then surged by 278.29% to $8190.0 in 2019, then surged by 75.56% to $14378.0 in 2020.
  • Business Quant data shows Depreciation Expense for AVAI at $14378.0 in Q4 2020, $14256.0 in Q3 2020, and $11567.0 in Q2 2020.